USFDA completes inspections at Solara Active Pharma's Puducherry, Mangalore facility

24 Feb 2020 Evaluate

United States Food and Drug Administration (USFDA) has completed two successful inspections of Solara Active Pharma Science’s state of the art manufacturing facilities at Puducherry and Mangalore. The inspection established that the two sites are in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from USFDA. The agency with their designated auditors inspected the two facilities from February 17 to 21, 2020.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

509.40 -24.55 (-4.60%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...